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A B S T R A C T
Introduction: Rapid diagnosis of bacterial infection is an important for patient management and appro-
priate therapy during the early phase of bacteria-induced disease. Among the existing techniques for
identifying pathogens were less sensitive and time-consuming processes. PCR has the beneﬁts of excel-
lent sensitivity, resolution and reproducibility.
Materials and methods: A multiplex PCR assay was designed for simultaneous detection and diagnosis
of C. perfringens, P. aeruginosa and K. pneumoniae in different clinical samples. A total of 46 clinical samples
of patients suspected with the infections were obtained from Sri Venkateswara Institute of Medical Sci-
ences, and used in the present study as test samples for detecting the pathogens.
Results and conclusions: Through this approach, the above pathogens were detected simultaneously with
high speciﬁcity in pure cultures and from the blood and urine samples. The results were correlated with
normal diagnostic process, and proved to be more sensitive and speciﬁc diagnostic technique in the si-
multaneous detection of C. perfringens, P. aeruginosa and K. pneumoniae.
© 2015 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Pathologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Clostridium perfringens, Pseudomonas aeruginosa and Klebsiella pneumonia are the prevalent bacterial infections that cause a range of
serious illness. Clostridium perfringens is considered to be one of the common microorganisms that cause human and veterinary diseases
[1]. Since C. perfringens cells and spores are normal inhabitants of gastrointestinal tracts of humans and animals, the spores are quite common
in soil. Infections due to C. perfringens show evidence of tissue necrosis, bacteremia, emphysematous cholecystitis, and gas gangrene, which
is also known as clostridial myonecrosis. Clostridium perfringens type A is the third most common cause of food-borne illness in the United
States [2] and the second most common cause in the United Kingdom [3].The symptoms and signs of C. perfringens diseases are due to
the production of numerous toxins that exhibit cytotoxic, hemolytic, hemorrhagic, necrotic, or other damaging effects on cells [4]. The
best known major human disease caused by C. perfringens is clostridial myonecrosis or gas gangrene.
Pseudomonas aeruginosa is an opportunistic human and plants pathogen. In plants, P. aeruginosa induces symptoms of soft rot in Arabidopsis
thaliana (Thale cress) and Lactuca sativa (lettuce). The associations of virulence factors are the same for plant and animal infections [5,6]. P. aeruginosa
survives in almost any environment, including water, soil, and plants, and is known for its nutritional and ecological ﬂexibility [7]. In humans,
P. aeruginosa is one of the leading causes of nosocomial infections, particularly in the settings of epithelial cell injury and immune-compromised
patients such as those with severe burns, injuries, leukemia, acquired immuno-deﬁciency syndrome (AIDS) and cystic ﬁbrosis (CF) [8], and has
become one of the leading causes of hospital-acquired infections. P. aeruginosa causes serious infections, including bacteremia, septicemia, pneu-
monia, endocarditis, otitis, keratitis, osteomyelitis, osteochondritis,meningitis, andbrain abscesses in immuno-compromisedpatients [8]. P. aeruginosa
is responsible for 16% of nosocomial pneumonia cases, 12% of hospital-acquired urinary tract infections, 8% of surgical wound infection, and 10%
of bloodstream infections. In addition, neutropenic cancer and bonemarrow transplant patients are particularly susceptible to opportunistic in-
fections such as pneumonia and septicemia caused by P. aeruginosa, with attribute deaths reaching 30% [8].
K. pneumonia is an opportunistic pathogen of the Enterobacteriaceae family and is ubiquitous in the environment as well as mucosal
surfaces of humans and other mammals [9]. It is often the cause of nosocomial infections in immune-compromised individuals, elderly,
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and infants, but chronic alcoholics and individuals with diabetes mellitus have also been observed to be particularly susceptible to this
pathogen [9,10]. K. pneumonia causes infections ranging from respiratory and urinary tract infections to bacteremia and septicemia, and
recently the presentation of liver abscesses has accompanied infections in Taiwan and South [9–11]. Healthy individuals show variation
in the carrier rates of K. pneumonia, with increased rates among individuals in hospital settings [9]. This high rate of nosocomial coloni-
zation is related to the use of antimicrobial agents [9,12]. While this organism is part of the normal ﬂora, it has the potential to cause
diverse diseases such as pneumonia, urinary tract infections, bacteremia, diarrhea, and wound infections. Initially, K. pneumonia was con-
sidered a major cause of community-acquired pneumonia [12]. Klebsiella is a bacterium that lives in the intestinal tract in about 40% of
all people. This bacterium does have the ability to cause symptoms within the digestive tract, although these tend to be “opportunistic”
infections. Although Klebsiella can also infect the urinary tract, the most serious site of infection is the lungs, where it can cause a rapidly
evolving and damaging form of pneumonia.
In clinical microbiology laboratories today, the identiﬁcation of bacterial infections generally involves gram’s staining preparations and cul-
tural characteristics. C. perfringens organism typically is a large, boxcar-shaped, gram-positive rod sub-terminal spore, andwhen cultured in anaerobe
blood agar plates under anaerobic conditions at 35°C, creamy yellow to gray colonies are formed within 24 hours. The colony margins can be
smooth, giving the appearance of a round, slightly raised colony, or rough, in which case the colonies are relatively ﬂat. A characteristic feature
of C. perfringens is a double-zone of hemolysis. P. aeruginosa on grams staining appears as gram-negative rod-shaped bacteriumwhich onMacConkey
agar plate produces colorless colonies (as it does not ferment lactose).When grown on cetrimide agar, P. aeruginosamay express the exopigment
pyocyanin, which is blue-green in color, and the colonieswill appear ﬂat, large, and oval. It also has a characteristic fruity smell. Klebsiella on gram’s
staining appears as gram-negative, rod-shaped and conﬁrmed by blood test and sputum cultures.
Even though these pathogens can be identiﬁed by culture-based methods and biochemical tests, early detection and speciﬁc identi-
ﬁcation of pathogens is necessary for the successful treatment of these diseases. Nucleic acid-based tests (NATs) have been raised in clinical
laboratories to identify pathogens more rapidly and reliably. Thus pathogen-speciﬁc genes were identiﬁed and individual PCR assays have
been developed for detection of Clostridium perfringens [13], Klebsiella pneumonia [14] and Pseudomonas aeruginosa [15]. However, indi-
vidual PCR assays when used for the detection of a large number of samples would be costly and time-consuming process. Multiplex PCR
approach reduces the cost, time factor and used for the simultaneous detection of a range of pathogens. Thus it also provides informa-
tion regarding multiple infections. Keeping this in view, our present study was to establish multiplex PCR assay for the above three pathogens,
which will provide a sensitive diagnostic approach for the detection and identiﬁcation of these infections.
2. Materials and methods
Experiments pertaining to the present research work were carried out at Watson life Sciences, Tirupati, Andhra Pradesh. Unless oth-
erwise stated, culture media and all the other chemicals used in this study were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
2.1. Collection of samples
Blood and urine samples used in the present study were collected from SVIMS (Sri Venkateswara Institute of Medical Sciences, Tirupati).
Bacterial cultures of C. perfringens, P. aeruginosa and K. pneumoniae, which were used in the present study as controls, were obtained from
ATTCC. A total of 37 blood samples and 9 urine samples were collected from different patients and mentioned in the present study as B1,
B2, B3——B37 and U1, U2, U3—-U9 respectively. These samples were used to diagnose C. perfringens, P. aeruginosa and K. pneumoniae infections
by using multiplex PCR.
2.2. Genomic DNA isolation from bacterial culture
Genomic DNA was isolated from the bacterial cultures of C. perfringens, P. aeruginosa, K. pneumoniae, E. coli, Salmonella, and V. cholera
grown in LB broth medium [16].
2.3. Genomic DNA isolation from blood samples
Genomic DNA was isolated from the blood samples by following the protocol given by using MEDOX-Easy Ultrapure Genomic DNA
Spin Mini preps Kit from blood sample (MX-0607) according to the manufacturer’s instructions.
2.4. Genomic DNA isolation from urine samples
Genomic DNA was isolated from the blood samples by using Urine Bacteria Genomic DNA Isolation Kit (22400) according to the ma-
nufacturer’s instructions (© Norgen Biotek Corp).
2.5. Determination of concentration and integrity of DNA samples
Spectrophotometer was used to quantify the concentration of DNA samples according to Sambrook et al. [17]. Samples were diluted with
water and the absorbance was then measured at wavelengths of 260 nm and 280 nm. The ratio between Abs260/Abs280 was used to check the
purity of the sample. A sample with a ratio of about 1.8 was considered as pure. Concentration of DNA was determined by using the equation
Abs 260 nm × dilution factor × 50. Integrity of the DNA samples was analyzed by subjecting the samples to 1% agarose gel electrophoresis.
2.6. Development of multiplex PCR
Genes speciﬁc for bacterial species were selected as markers for the identiﬁcation of particular species. Cpa, Ecfx and bla LEN genes
were selected as markers for the C. perfringens, P. aeruginosa and K. pneumoniae, respectively, and primers for these genes were taken from
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the literature [13–15]. These primers were slightly modiﬁed so as to multiplex the PCR assay. Primer BLAST was performed to verify the
identity, gaps, complementarity and amplicon size. Tm was calculated by using sabina.anzlovar.com, an online tool that uses formula
64 + (g + c − 16.4)/(a + t + c + g) for calculating primers with more than 13 base pairs. GC%, primer dimer formation and secondary struc-
ture analysis of the primers were validated by using Sigma DNA calculator an online tool (Table 1).
The PCR conditions were optimized and given as follows: 2.5 mM MgCl2, 0.2 mM of each deoxy nucleoside tri-phosphate, 1U of Taq
DNA polymerase (Fermentas), 1 μl of DNA template, and 6 μM of each primer. Temperature conditions were as follows: initial denatur-
ation at 95°C/3 min, denaturation at 94°C/1 min, hybridization at 60°C/1 min and polymerization at 72°C/2 min and kept for 35 PCR cycles.
The PCR amplicons (10 μl) were electrophoresed at 70 volts for approximately 0.5 hour through 1.5% agarose (Fermentas). The gel was
then stained with ethidium bromide (10 mg/ml) and visualized under UV light. When a negative ampliﬁcation was obtained, a new PCR
was performed and 20 μl of the resultant solution was run on an agarose gel to conﬁrm the result.
2.7. Sensitivity and speciﬁcity of primers
The primers were tested for their sensitivity of simultaneous detection of C. perfringens, P. aeruginosa and K. pneumoniae at various con-
centrations (10–105) of bacteria homogenate. Sensitivity of the assay was analyzed by using pure DNA at different concentrations, i.e.,
from 10 to 100 picograms as template.
2.8. Data analysis
The banding pattern of the multiplex PCR data was analyzed and compared with the normal diagnostic results.
3. Results
Out of 37 blood samples, 20 samples (i.e., B1–B20) showed a PCR product of approximately 152 base pairs in length, which is speciﬁc
to P. aeruginosa (Fig. 1), 7 samples (i.e., B21–B27) showed an ampliﬁcation product of 324 bp, which is speciﬁc to C. perfringens (Fig. 2), and
10 samples (B3, B5, B7, B11, B29, B30, B31, B32, B34, B35, B36, B37) showed an ampliﬁcation product of 591 base pairs in length, which is speciﬁc
Table 1
Genes, organism name, accession number, primer sequence, amplicon size, Tm, secondary structure, primer dimer formation, GC%, identity of Cpa, Ecfxb.
Gene Organism Accession
number
Primer sequence (5′-3′) Amplicon size Tm
(°C)
Sec
structure
Primer
dimer
GC % BLAST
Identity Gaps
cpa Clostridium perfringens JN793988.1 F: GCTAATGTTACTGCCGTTGA 325 63.63 None No 45 100% 0%
R:
CCTCTGATACATCGTGTAAGAATC
63.7 Weak No 41.67
Ecfxb Pseudomonas aeruginosa DQ996551 F: TTCCATGGCGAGTTGCT 152 63.56 None No 52.94 100% 0%
R: CGGGCGATCTGGAAAA 63.53 None No 56.25
blaLEN Klebsiella pneumonia HQ709169.1 F: ATGCGTTATGTTCGCCTG 591 63.58 Moderate No 50 100% 0%
R: GGCGCTCAGATGCTG 63.57 Weak No 66.67
Fig. 1. Ampliﬁcation products obtained from blood samples using mPCR assay designed speciﬁcally for the detection of C. perfringens, P. aeruginosa and K. pneumoniae. Lanes
B1–B20 show 154 bp product, which shows that these samples were positive for Pseudomonas aeruginosa. Samples B3, B5, B7, B11 show 591 bp PCR product along with 154 bp
products, which indicates these samples were positive for both Klebsiella pneumonia and Pseudomonas aeruginosa.
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to K. pneumoniae (Fig. 3). Four samples (i.e., B3, B5, B7, B11) showed two bands of 152 and 591 bp, which are speciﬁc to P. aeruginosa and
K. pneumoniae. These results indicate that the blood samples B1–B20 were positive to P. aeruginosa, samples B21–B27 were positive to C. perfringens,
samples B3, B5, B7, B11, B29, B30, B31, B32, B34, B35, B36, B37 were positive to K. pneumoniae, and samples B3, B5, B7, B11 were positive for both
P. aeruginosa and K. pneumoniae. Our values were 100% correlated with normal diagnostic tests, which clearly indicate the speciﬁcity of
our assay.
Out of 9 urine samples, 7 samples, i.e., U1–U6 and U9 showed an ampliﬁcation product of 591 bp in length (Fig. 4), which clearly indi-
cates that these samples were positive to K. pneumoniae. Our values were 100% correlated with normal diagnostic tests, which clearly
indicate the speciﬁcity of our assay. Regarding the sensitivity by using pure DNA at different concentrations as template, faint bands were
seen at the minimum concentrations of 40 pg for P. aeruginosa and 50 pg for both C. perfringens and K. pneumoniae.
Fig. 2. Ampliﬁcation products obtained from blood samples using mPCR assay designed speciﬁcally for the detection of C. perfringens, P. aeruginosa and K. pneumoniae. Lanes
B21–B27 show 324 bp product, which shows that these samples were positive for Clostridium perfringens. Samples B24, B25 and B27 show high intensity bands of 324 bp product,
which indicates high infection of Clostridium perfringens.
Fig. 3. Ampliﬁcation products obtained from blood samples using mPCR assay designed speciﬁcally for the detection of C. perfringens, P. aeruginosa and K. pneumoniae. Lanes
B29, B30, B31, B32, B34, B35, B36, B37 show 591bp product, which shows that these samples were positive for Klebsiella pneumonia.
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4. Discussion
In this study we aimed to detect multiple pathogens by using multiplex PCR in order to replace the current tedious, less sensitive and
less speciﬁc detection technologies in clinical and foodmicrobiological analysis. Through this technique simultaneous detection of C. perfringens,
P. aeruginosa and K. pneumoniae infections in a given sample can be possible. Here we designed three species speciﬁc primers for simul-
taneous detection of C. perfringens, P. aeruginosa and K. pneumoniae, which conserved as a diagnostic assay for gastrointestinal illness and
lung infections. For this purpose speciﬁc genes were selected from the three target bacterial pathogens. Cpa, Ecfx and bla LEN genes were
selected as markers for the C. perfringens, P. aeruginosa and K. pneumoniae, respectively, and primers for these genes were taken from the
literature [13–15]. These primers were slightly modiﬁed so as to multiplex the PCR assay. The cpa gene of C. perfringens, which encodes
the α toxin, was taken as a marker gene for the identiﬁcation of C. perfringens and unique primers were designed for it. ecfxb gene was
constitutive and unique gene found in P. aeruginosa, so it was taken as marker for the detection of P. aeruginosa .The chromosomally encoded
ß-lactamase b/a LEN and b/a OKP genes, which so far only have been found in K. pneumoniae selected to detect K. pneumoniae. By incor-
porating these primers into a single detection assay, we developed a multiplex PCR assay to concurrently detect these bacteria. An important
factor in evaluating any DNA-based test is the speciﬁcity of the DNA sequence chosen for the genes and strains of interest. The advantage
of our method is the ability of PCR to amplify speciﬁcally a gene or a segment of gene directly from a sample containing various bacterial
strains. One of the problems often encountered with multiplex PCR is a reduction in sensitivity. This may be because of the competition
between individual reactions for dNTPs and Taq polymerase when multiple primer sets are combined in a single reaction. However, we
were able to demonstrate that products could be ampliﬁed from all three targets in the same reaction. The present approach doesn’t rely
on DNA isolation [18] process moreover the boiling of cultures provides adequate nucleic acid to detect sequences of interest. Boiling the
bacterial cells in the presence of 1% triton X-100 in this study enhanced the eﬃciency of DNA extraction being an additional advantage of
the present method. To overcome PCR inhibition problems and to increase the sensitivity of the assay, enrichment method was em-
ployed. The higher sensitivity of the assay may be due to the dilution of inhibitory substances in the enrichment broth and the increased
number of organisms. Media enrichment also helps in viable bacterial population which is always looked for the routine microbiological
detection procedures. Hence the probability of hitting DNA from dead cells is signiﬁcantly reduced to its minimum possible level. While
detecting many potentially pathogenic organisms not yielded on culturing, 16S rDNA PCR did not detect all signiﬁcant infections. In the
present study, blood and urine samples showed 100% PCR positive results. Furthermore using the pure DNA as template, the sensitivity
was found to be 40 pg for P. aeruginosa and 50 pg for both C. perfringens and K. pneumoniae.
5. Conclusions
In conclusion, we have developed a rapid, simple and convenient m-PCR-based assay for the speciﬁc and simultaneous detection of
three major food and water-borne pathogens. This rendered ﬁnal results in hours rather than lengthy and equally expensive biochemical
methods. Application of this method in food industries and municipal water supply departments is an additional beneﬁt attributed to
this technique.
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